NO890260D0 - Fremgangsmaate ved fremstilling av cytostatin c eller modifikasjoner derav og dna-sekvens for anvendelse ved utfoerelse av fremgangsmaaten. - Google Patents

Fremgangsmaate ved fremstilling av cytostatin c eller modifikasjoner derav og dna-sekvens for anvendelse ved utfoerelse av fremgangsmaaten.

Info

Publication number
NO890260D0
NO890260D0 NO1989890260A NO890260A NO890260D0 NO 890260 D0 NO890260 D0 NO 890260D0 NO 1989890260 A NO1989890260 A NO 1989890260A NO 890260 A NO890260 A NO 890260A NO 890260 D0 NO890260 D0 NO 890260D0
Authority
NO
Norway
Prior art keywords
procedure
cytostatin
preparing
carrying
modifications
Prior art date
Application number
NO1989890260A
Other languages
English (en)
Other versions
NO890260L (no
NO301985B1 (no
Inventor
Anders Grubb
Aake Lundwall
Magnus Abrahamson
Henrik Dalboege
Original Assignee
Nordisk Gentofte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte
Publication of NO890260L publication Critical patent/NO890260L/no
Publication of NO890260D0 publication Critical patent/NO890260D0/no
Publication of NO301985B1 publication Critical patent/NO301985B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO890260A 1987-05-22 1989-01-20 Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten NO301985B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK260987A DK260987D0 (da) 1987-05-22 1987-05-22 Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden
PCT/DK1988/000082 WO1988009384A1 (en) 1987-05-22 1988-05-20 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method

Publications (3)

Publication Number Publication Date
NO890260L NO890260L (no) 1989-01-20
NO890260D0 true NO890260D0 (no) 1989-01-20
NO301985B1 NO301985B1 (no) 1998-01-05

Family

ID=8113675

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890260A NO301985B1 (no) 1987-05-22 1989-01-20 Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten

Country Status (12)

Country Link
EP (1) EP0362259B1 (no)
JP (1) JP3011274B2 (no)
AT (1) ATE135049T1 (no)
AU (1) AU619750B2 (no)
CA (1) CA1340862C (no)
DE (1) DE3855078T2 (no)
DK (1) DK260987D0 (no)
ES (1) ES2013337A6 (no)
FI (1) FI102191B (no)
IL (1) IL86476A (no)
NO (1) NO301985B1 (no)
WO (1) WO1988009384A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002820A1 (en) * 1988-11-18 1990-05-18 Kazunori Hanada Pharmaceutical use for cystatins
GB9122051D0 (en) * 1991-10-17 1991-11-27 Univ Nottingham Medicines
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
EP1231274A3 (en) * 1994-11-21 2002-10-09 The University Of Leeds Modified porteinase inhibitors
AU738766B2 (en) * 1994-11-21 2001-09-27 University Of Leeds, The Modified proteinase inhibitors
CA2223888A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human cystatin e
US6011012A (en) 1995-06-05 2000-01-04 Human Genome Sciences, Inc. Human cystatin E
EP1123399A2 (en) * 1998-08-05 2001-08-16 The University Of British Columbia Production and use of modified cystatins
AU2178000A (en) * 1998-12-11 2000-06-26 Salk Institute For Biological Studies, The Co-factors for trophic factors, and methods of use thereof
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
AU2012386758C1 (en) * 2012-07-31 2017-03-30 Megmilk Snow Brand Co., Ltd. Novel protein material
CN102895658A (zh) * 2012-08-23 2013-01-30 苏州大学附属第一医院 Cystatin C在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
CN106119286A (zh) * 2016-08-10 2016-11-16 吴江近岸蛋白质科技有限公司 表达载体及其高效表达和制备人胱抑素c蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
IL86476A (en) 1994-01-25
DK260987D0 (da) 1987-05-22
AU1939988A (en) 1988-12-21
NO890260L (no) 1989-01-20
NO301985B1 (no) 1998-01-05
IL86476A0 (en) 1988-11-15
FI102191B1 (fi) 1998-10-30
DE3855078D1 (de) 1996-04-11
DE3855078T2 (de) 1996-07-18
CA1340862C (en) 1999-12-28
JP3011274B2 (ja) 2000-02-21
EP0362259B1 (en) 1996-03-06
JPH03501201A (ja) 1991-03-22
EP0362259A1 (en) 1990-04-11
ATE135049T1 (de) 1996-03-15
AU619750B2 (en) 1992-02-06
ES2013337A6 (es) 1990-05-01
FI895553A0 (fi) 1989-11-21
FI102191B (fi) 1998-10-30
WO1988009384A1 (en) 1988-12-01

Similar Documents

Publication Publication Date Title
NO890260D0 (no) Fremgangsmaate ved fremstilling av cytostatin c eller modifikasjoner derav og dna-sekvens for anvendelse ved utfoerelse av fremgangsmaaten.
FI922812A (fi) Stabil oeverfoering av dna till bakteriernas arvanslag.
DE59002925D1 (de) Elektrolysezelle zur herstellung von peroxo- und perhalogenatverbindungen.
DE3864585D1 (de) Dns-molekule, codierend fuer non-a-non-b-hepatitis-antigene und ihre verwendung zur herstellung dieser antigene.
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
ES2163392T3 (es) Nuevas secuencias expresadas preferentemente en el desarrollo de semillas precoces, y procedimientos relacionados con las mismas.
DE68929551D1 (de) Menschliche DNase
NO873753D0 (no) Periodisk biologisk luftbehandlingsprosess og system for denne.
DE3872070D1 (de) Filter, das ein durch gefriertrocknung hergestelltes material enthaelt, herstellung und verwendung desselben, insbesondere in der galenik.
DE68911915D1 (de) Methode und gerät zur verwendung bei der herstellung wiederverstärkter holzerzeugnisse.
DE3560196D1 (en) Process for the preparation of 1,2,3-trichloro-2-methyl-1-propane
EP0653491A4 (en) METHOD FOR INTRODUCING FOREIGN DNA IN CELLS.
FI880383A (fi) Transformation och expression av en fraemmande gen i brassicaarter.
DE3883408D1 (de) Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen.
DE59003144D1 (de) Destillationsanlage zur Herstellung von Wasserstoff-Peroxid.
DE3767893D1 (de) Verfahren zur herstellung von polysaccharidethern unter verwendung eines reaktors mit mehrstufigem ruehrorgan und strombrechern.
ZA876248B (en) Polypeptides of the rhinovirus strain hrv89 and the dna molecules coding therefor
ES2054230T3 (es) Un proceso para la preparacion de un enterovirus o rinovirus atenuado.
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
DE68924222D1 (de) Megakaryocytopoietin, seine Herstellung und Benutzung.
ATE109509T1 (de) Anticoagulatorisches protein pp4-x, seine herstellung und verwendung.
DK583589A (da) Fremgangsmaade til fremstilling af cystatin c eller modifikationer heraf og dna-sekvens til brug ved udoevelse af fremgangsmaaden
DE69123344D1 (de) Künstliches blutgefäss sowie herstellung desselben
DE3688225D1 (de) Herstellung menschlichen somatomedins c.
DE69007941D1 (de) Mesophasepech zur Herstellung von Carbonmaterialien.

Legal Events

Date Code Title Description
MK1K Patent expired